AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
+14.47%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$4.73B
AUM Growth
+$4.73B
(+8.1%)
Cap. Flow
+$208M
Cap. Flow
% of AUM
4.4%
Top 10 Holdings %
Top 10 Hldgs %
47.54%
Holding
160
New
25
Increased
29
Reduced
25
Closed
13
Top Buys
| 1 |
Intel
INTC
|
$51.2M |
| 2 |
IMA
ImageneBio, Inc. Common Stock
IMA
|
$43.8M |
| 3 |
argenx
ARGX
|
$41.3M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$38.5M |
| 5 |
ACHL
Achilles Therapeutics plc American Depositary Shares
ACHL
|
$37.3M |
Top Sells
| 1 |
GDS Holdings
GDS
|
$73M |
| 2 |
Zillow
Z
|
$58.3M |
| 3 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$52.2M |
| 4 |
Alibaba
BABA
|
$46.5M |
| 5 |
uniQure
QURE
|
$25.3M |
Sector Composition
| 1 | Healthcare | 82.42% |
| 2 | Consumer Discretionary | 10.44% |
| 3 | Technology | 2.06% |
| 4 | Communication Services | 0.94% |
| 5 | Real Estate | 0.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Taysha Gene Therapies
TSHA
$791M
| $21.1M | 0.37% |
1,040,882
| – | – |
|
|
HARP
52
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $20.9M | 0.37% |
1,000,000
+200,000
| +25% | +$4.18M |
|
|
DRNA
53
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $20.5M | 0.36% |
+800,000
| New | +$20.5M |
|
54
Curis
CRIS
$21.5M
| $20.4M | 0.36% |
1,804,729
| – | – |
|
55
Cartesian Therapeutics
RNAC
$267M
| $20.4M | 0.36% |
4,500,000
| – | – |
|
56
Intellia Therapeutics
NTLA
$1.26B
| $20.1M | 0.35% |
250,000
| – | – |
|
57
Coupang
CPNG
$51.6B
| $19.7M | 0.35% |
+400,000
| New | +$19.7M |
|
58
Mersana Therapeutics
MRSN
$34.8M
| $19.4M | 0.34% |
1,200,000
| – | – |
|
|
APTX
59
DELISTED
Aptinyx Inc. Common Stock
APTX
| $18.3M | 0.32% |
6,116,493
+3,614,458
| +144% | +$10.8M |
|
|
BLU
60
DELISTED
BELLUS Health Inc.
BLU
| $18.2M | 0.32% |
4,750,000
| – | – |
|
61
iQIYI
IQ
$2.61B
| $17M | 0.3% |
1,025,000
+175,000
| +21% | +$2.91M |
|
62
Kura Oncology
KURA
$732M
| $17M | 0.3% |
600,000
| – | – |
|
63
Repare Therapeutics
RPTX
$73.9M
| $16.9M | 0.3% |
550,000
-20,000
| -4% | -$614K |
|
|
TCRR
64
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $16.6M | 0.29% |
750,000
+250,000
| +50% | +$5.52M |
|
|
TBIO
65
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $16.5M | 0.29% |
1,000,000
-200,000
| -17% | -$3.3M |
|
|
AGEN
66
Agenus
AGEN
$136M
| $16.3M | 0.29% |
6,000,000
-900,000
| -13% | -$2.45M |
|
67
BridgeBio Pharma
BBIO
$9.91B
| $15.4M | 0.27% |
250,000
-50,000
| -17% | -$3.08M |
|
|
NBTX
68
Nanobiotix
NBTX
$415M
| $15M | 0.27% |
1,000,000
| – | – |
|
|
ADAG
69
Adagene
ADAG
$103M
| $14.4M | 0.25% |
+800,000
| New | +$14.4M |
|
70
Zymeworks
ZYME
$1.07B
| $14.2M | 0.25% |
450,000
+100,000
| +29% | +$3.16M |
|
71
Relay Therapeutics
RLAY
$709M
| $13.8M | 0.24% |
400,000
| – | – |
|
72
Sana Biotechnology
SANA
$759M
| $13.4M | 0.24% |
+400,000
| New | +$13.4M |
|
|
YI
73
111 Inc
YI
$52M
| $13.3M | 0.24% |
966,349
-33,651
| -3% | -$464K |
|
|
ORTX
74
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $13.1M | 0.23% |
1,803,858
+1,452,358
| +413% | +$10.5M |
|
75
Aurinia Pharmaceuticals
AUPH
$1.58B
| $13M | 0.23% |
1,000,000
| – | – |
|